Atlas Trials

Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood

Clinical trial NCT04496154 · COMPLETED

Trial details

NCT number
NCT04496154
Sponsor
May Faraj, PDt, PhD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 DiabetesInsulin Sensitivity/ResistanceInflammatory ResponseFatty Acids, Omega-3
Start date
2013-09-05
Primary completion
2020-01-22
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.